IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Takeda Pharmaceutical Co LTD

Q1 2025 Holdings

Filed 2025-05-12 | 12 holdings | $16.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
HilleVax, Inc.COM43157M102$9.8M6,724,00060.2%
Ovid Therapeutics, Inc.(OVID)COM690469101$2.3M7,531,99614.5%
Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)(XLO)COM98422T100$1.1M1,475,1216.6%
Equillium, Inc.(EQ)COM29446K106$711.7K1,824,9774.4%
American Well Corporation(AMWL)COM03044L204$612.5K77,7333.8%
Shattuck Labs, Inc.(STTK)COM82024L103$489.8K515,6193.0%
Lyell Immunopharma, Inc.COM55083R104$442.9K823,3172.7%
Turnstone BiologicsCOM90042W100$367.3K895,8242.3%
Rani Therapeutics Holdings, Inc.(RANI)COM753018100$256.0K203,1901.6%
Third Harmonic Bio, Inc.(THRD)COM88427A107$127.8K36,8350.8%
Standard Biotools, Inc.(LAB)COM34385P108$17.8K16,5150.1%